BIOMAT Database Logo BIOMAT Database Logo

Immunoreactive insulin and glucose response to oral glucose in offspring of patients with endogenous hypertriglyceridaemia. 1977

B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia.
April 1978, Diabetologia,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Insulin response to oral glucose in patients with preeclampsia.
January 1973, Danish medical bulletin,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Insulin response to intravenous glucose in patients with anorexia nervosa showing low insulin response to oral glucose.
July 1994, The Journal of clinical endocrinology and metabolism,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia.
May 1983, Metabolism: clinical and experimental,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
June 1972, Israel journal of medical sciences,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
January 1982, International journal of obesity,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Diminished glucose tolerance and immunoreactive insulin response in patients with nonischemic cardiac disease.
September 1968, Circulation,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Impaired plasms immunoreactive insulin response to glucose in elderly hypertensive patients with abnormal clucose tolerance.
August 1979, Age and ageing,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Impact of oral anticholinergic on insulin response to oral glucose load in patients with impaired glucose tolerance.
January 2021, Indian journal of pharmacology,
B Werbin, and I Tamir, and D Heldenberg, and D Ayalon, and M Adler, and O Levtow
Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man.
July 1975, International journal of clinical pharmacology and biopharmacy,
Copied contents to your clipboard!